article_snippet: A new injectable drug designed to eliminate double chins without surgery was unanimously recommended for approval by a Food and Drug Administration advisory committee this week.
article_snippet: Unlike current double chin surgeries, which require doctors to 'cut final FDA approval out or suck final FDA approval out,' ATX-101 will be a 'noninvasive, in-the-office procedure,' according to Dr. Susan Weinkle.
article_snippet: A dermatologist prepares the injection site for ATX-101, a new injectable drug  designed to eliminate double chins without surgery that was unanimously recommended for approval by an FDA advisory committee .
article_snippet: ATX-101 works by eliminating the membrane of fat cells underneath the double chin.
article_snippet: To insert the drug, Dr. Susan Weinkle marks the area where she sees the 'max amount of fat' with a grid of tiny dots, which act as the injection sites for ATX-101.
article_snippet: Dr. Derek Jones, who presented ATX-101 to the FDA, said the drug destroys the membrane of the fat cells underneath the double chin.
highlights_snippet: Drug is injected in grid of tiny dots where 'max amount of fat' under chin is .
  